Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis

Lluís Rusiñol,Lluís Puig
DOI: https://doi.org/10.3390/ijms25021042
IF: 5.6
2024-01-15
International Journal of Molecular Sciences
Abstract:Psoriasis and atopic dermatitis fall within the category of cutaneous immune-mediated inflammatory diseases (IMIDs). The prevalence of IMIDs is increasing in industrialized societies, influenced by both environmental changes and a genetic predisposition. However, the exact immune factors driving these chronic, progressive diseases are not fully understood. By using multi-omics techniques in cutaneous IMIDs, it is expected to advance the understanding of skin biology, uncover the underlying mechanisms of skin conditions, and potentially devise precise and personalized approaches to diagnosis and treatment. We provide a narrative review of the current knowledge in genomics, epigenomics, and proteomics of atopic dermatitis and psoriasis. A literature search was performed for articles published until 30 November 2023. Although there is still much to uncover, recent evidence has already provided valuable insights, such as proteomic profiles that permit differentiating psoriasis from mycosis fungoides and β-defensin 2 correlation to PASI and its drop due to secukinumab first injection, among others.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to improve the diagnosis and treatment of atopic dermatitis and psoriasis through a multi - omics approach. Specifically, the author hopes to integrate the data of genomics, epigenomics and proteomics to deeply understand the biological mechanisms of these two cutaneous immune - mediated inflammatory diseases (IMIDs), thereby providing theoretical basis and technical support for precision medicine. ### Background and Objectives of the Paper 1. **Background**: - Atopic dermatitis and psoriasis are common cutaneous immune - mediated inflammatory diseases, and their incidences are gradually increasing in industrialized societies, which are affected by environmental changes and genetic factors. - Although the existing treatment methods are effective to a certain extent, long - term disease control remains a challenge. - The development of multi - omics technologies provides new tools for in - depth study of the molecular mechanisms of these diseases. 2. **Objectives**: - **Understand skin biology**: Use multi - omics technologies to understand the biological characteristics of the skin more comprehensively. - **Reveal disease mechanisms**: Discover the potential pathogenic mechanisms of atopic dermatitis and psoriasis. - **Personalized diagnosis and treatment**: Based on multi - omics data, develop more accurate and personalized diagnosis and treatment plans. ### Main Contents 1. **Introduction**: - Introduced the basic pathophysiological characteristics of atopic dermatitis and psoriasis. - Emphasized the importance of multi - omics technologies in dermatological research. 2. **Materials and Methods**: - Described in detail the methods of literature retrieval, including the databases used, keywords and inclusion criteria. 3. **Current Knowledge**: - **Atopic dermatitis**: Discussed its genetic background, epidermal barrier dysfunction and inflammation response mechanisms. - **Psoriasis**: Explored its genetic background, the interaction between keratinocytes and the immune system and the mechanism of maintaining chronic inflammation. 4. **Multi - omics Studies**: - **Genomics**: Summarized the genetic risk factors of atopic dermatitis and psoriasis, including known susceptibility genes and loci. - **Epigenetics**: Discussed the role of epigenetic modifications in the occurrence and development of diseases. - **Proteomics**: Introduced the application of proteomics in distinguishing different skin diseases, such as distinguishing psoriasis and mycosis fungoides by protein profiles. ### Conclusion This paper aims to provide new insights and methods for precision medicine of atopic dermatitis and psoriasis by integrating multi - omics data. Through these studies, the biological mechanisms of these two diseases can be better understood, thereby providing more effective strategies for clinical diagnosis and treatment.